Publications
485
Citations
12,330
Est. group size
~28
Recurring co-author estimate
Active years
27
Publishing since 2000
Typically publishes in teams of ~7 · 7% small-team papers (≤3 authors) · across 17 venues
- 869 p53 Expression is Associated with Recurrence-Free Survival in Prostate Cancer: Interaction with PTEN
Laboratory Investigation · 2025
- 1769 A Quality Improvement Study on Pathology Explanation Clinics in Veterans with Prostate Cancer
Laboratory Investigation · 2025
- Effectiveness of out-of-pocket cost COMmunication and financial navigation (CostCOM) in cancer patients: Study protocol for ECOG-ACRIN EAQ222CD
Contemporary Clinical Trials · 2025
- Real-world adherence to guideline-based therapy in early-stage mucinous ovarian cancer
Gynecologic Oncology · 2025
- The Acceptance and Use of Digital Technologies for Self-Reporting Medication Safety Events After Care Transitions to Home in Patients With Cancer: Survey Study
Journal of Medical Internet Research · 2024
- Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study
Modern Pathology · 2023
- The Acceptance and Use of Digital Technologies for Self-Reporting Medication Safety Events After Care Transitions to Home in Patients With Cancer: Survey Study (Preprint)
2023
- Data from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Supplementary Figure 4 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Supplementary Table 3 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Supplementary Figure 2 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Supplementary Table 1 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Supplementary Figure 3 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Supplementary Table 2 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Supplementary Table 4 from Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
2023
- Journal of Clinical Oncology×58
- Cancer×16
- JCO Oncology Practice×11
- Breast Cancer Research and Treatment×6
- Annals of Surgical Oncology×6
- Steven J. Katz
Medicine · University of Michigan
- Archana Radhakrishnan
Medicine · University of Michigan
- Clare E. Jacobson
Medicine · University of Michigan
- James L. Fisher
Medicine · The Ohio State University
- Samilia Obeng‐Gyasi
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile